The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Getting the one-dose RSV vaccine is one of the easiest ways to do so ... year from RSV and the state of Oklahoma saw a ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...

The RSV vaccine leads to better health outcomes among older adults with IBD, including a lower risk for RSV pneumonia.

Older people with RSV are at higher risk of severe illness compared to those with influenza or COVID. Vaccines Protect Against Severe Symptoms and Keep People Out of the Hospital In 2023 ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...